BI-RADS Sixth Edition: A New Era for Lymph Node Imaging

The upcoming BI-RADS Sixth Edition introduces significant updates for regional breast lymph node evaluation. Consequently, radiologists must adapt to these shifting standards for staging and treatment planning. Specifically, the new guidelines reflect a move toward de-escalating axillary management. This trend aims to reduce lymphedema risks while maintaining excellent patient outcomes. Accordingly, the medical community eagerly awaits the finalized atlas.

New Dedicated Categories in BI-RADS Sixth Edition

One major update involves the introduction of a dedicated lymph node category. Previously, clinicians reported nodes as associated features. However, the BI-RADS Sixth Edition provides a separate section for nodal reporting across all modalities. This change enhances clarity during mammography, ultrasound, and MRI interpretations. Furthermore, the lexicon now includes expanded guidance on node morphology. Practitioners will find more precise descriptors for cortical thickening and hilar loss. Consequently, this standardization improves communication between radiologists and surgeons. Moreover, it assists in identifying suspicious intramammary and internal mammary nodes.

Standardizing Multimodality Node Evaluation

The update emphasizes a systematic approach to multimodality imaging. Specifically, ultrasound remains the primary tool for guiding biopsies and fine-needle aspirations. In addition, MRI offers superior sensitivity for evaluating internal mammary nodes. Mammography continues to play a role in identifying abnormal axillary density. Therefore, clinicians must select the appropriate modality based on the clinical context. Each modality now has specific criteria for normal and abnormal appearances. This ensures consistent staging across different healthcare settings. Furthermore, these changes support the Choosing Wisely initiative by preventing over-treatment.

Impact on Clinical Staging and Management

Standardized reporting directly impacts breast cancer staging and subsequent treatment plans. For instance, identifying internal mammary involvement can change the radiation field. In contrast, identifying small, benign-appearing axillary nodes prevents unnecessary surgery. Additionally, the new guidance addresses nodal response after neoadjuvant therapy. Consequently, imaging plays a more central role in modern multidisciplinary care. Radiologists provide the critical data needed for precision medicine.

Frequently Asked Questions

Q1: What is the primary change in lymph node reporting for the BI-RADS Sixth Edition?

The update introduces a dedicated lymph node category across all imaging modalities, moving away from reporting them merely as associated features.

Q2: Why is de-escalation important in axillary management?

De-escalation reduces the risk of long-term complications like lymphedema without compromising survival rates or increasing local recurrence.

Q3: Which imaging modalities are covered under the new guidelines?

The guidelines provide specific evaluation criteria for mammography, ultrasound, and MRI regarding various regional nodal basins.

References

1. Retson TA et al. Multimodality Evaluation of Regional Breast Lymph Nodes: Impact of Expected Changes in the Upcoming BI-RADS Sixth Edition. Radiographics. 2026 May undefined. doi: 10.1148/rg.250188. PMID: 42060488.
2. Shahi A et al. Recent advances in breast imaging reporting: a review of the BI-RADS® sixth edition. Int J Community Med Public Health. 2026 Mar;13(3).
3. American College of Radiology. BI-RADS® v2025 Manual: 6th Edition. Reston, VA: ACR; 2025.